CONSHOHOCKEN, Pa. - Cencora, Inc. (NYSE: COR), a global pharmaceutical solutions organization, has successfully closed its public offering of $500 million in senior notes, the company announced today. The 5.125% Senior Notes, due in 2034, were sold in a registered public offering pursuant to a shelf registration statement filed with the Securities and Exchange Commission on November 23, 2021.
The net proceeds from the sale are earmarked primarily for the redemption of all outstanding 3.400% Senior Notes due on May 15, 2024. Cencora plans to allocate any remaining funds for general corporate purposes.
BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC, and Wells Fargo Securities, LLC acted as the joint book-running managers for the offering.
This news is based on a press release statement from Cencora, Inc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.